Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2003-06-25
2008-09-02
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
C530S351000
Reexamination Certificate
active
07419658
ABSTRACT:
The present invention relates to a G-protein coupled receptor and a novel ligand therefor. The invention provides screeing assays for the identification of candidate compounds which modulate the activity of the G-protein coupled receptor, as well as assays useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of G-protein coupled receptor signaling.
REFERENCES:
patent: 5948664 (1999-09-01), Williams et al.
patent: 6822072 (2004-11-01), Edwards et al.
patent: 2003/0022188 (2003-01-01), Macina et al.
patent: 2003/0096299 (2003-05-01), Wittamer et al.
patent: 2005/0084936 (2005-04-01), Lal et al.
patent: WO/00/31258 (2000-06-01), None
Adams, et al., “1,25 Dihydroxyvitamin D3 and Dexamethasone Induce the Cyclooxygenase 1 Gene in Osteoclast-Supporting Stromal Cells”, (1999),J. of Cellular Biochemistry, 74: 587-595.
Nagpal, et al., “Tazarotene-induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin”, (1997),J. Invest. Dermatol., 109: 91-95.
Samson, et al., “ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains”, (1998),Eur. J. Immunology, 28: 1689-1700.
Methner, et al., “A Novel G Protein-Coupled Receptor with Homology to Neuropeptide and Chemoattractant Receptors Expressed during Bone Development”, (1997),Biochemical and Biophysical Research Communications, 233: 336-342.
Kotani, M., M. Detheux, A. Vandengogaerde, D. Communi, J.M. Vanderwinden, E. Le Poul, S. Brezillon, R. Tyldesley, N. Suarez-Huerta, F. Vandeput, C. Banpain, S.N. Schiffmann, G. Vassart, and M. Parmentier, “The metastasis-suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54”, (2001),J.Biol.Chem. 276:34631-34636.
Joost, P., and A. Methner, “Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands”, (2002),Genome Biology3, 0063.1-0063.16.
Lee, D.K., S.R. George, J.F. Evans, K.R. Lynch, and B.F. O'Dowd, “Orphan G protein-coupled receptors in the CNS”, (2001),Curr. Opin. Pharacol. 1:31-39.
Im, D.S., “Orphan G protein-coupled receptors and beyond”, (2002),Jpn. J. Pharmacol, 90:101-106.
Communi D. et al “Receptors responsive to extracellular pyrimidine nucleotides” Trends in Pharmocological Sciences, 18(3):83-86 (Mar. 1, 1997).
Communi D. et al “Cloning of a Human purinergic P2Y receptor coupled to phospholipase C and adenyl cyclase” Journal of Biological Chemistry 272(51):31969-31973 (Dec. 19, 1997).
Owmen et al., Molecular cloning and tissue distribution of a novel chemo-attractant-like receptor, Biochem Biophys Res. Commun. Dec. 18, 1997:241(2):390-4.
Samson et al., ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains, Eur. J. Immunol. May 1998; 28(5): 1689-700.
Wittamer, et al., Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids, The Journal of Experimental Medicine, Oct. 6, 2003, vol. 198, No. 7, pp. 977-985.
Wittamer, et al., The C-terminal Nanopeptide of Mature Chemerin Activates the Chemerin Receptor with Low Nanomolar Potency, The Journal of Biological Chemistry, Mar. 12, 2004, vol. 279, No. 11, pp. 9956-9962.
International Search Report, dated Oct. 25, 2005, PCT/EP2004/006945.
Owman et al., “Molecular cloning and tissue distribution of a cDNA encoding a novel chemo-attractant-like receptor”, Biochemical and Biophysical Res. Commun. Dec. 18, 1997, vol. 241(2): pp. 390-394.
International Search Report, Oct. 22, 2003, PCT/EP/07647.
Brezillon Stephane
Communi David
Detheux Michel
Franssen Jean-Denis
Le Poul Emmanuel
Beaudet Matthew
Edwards Angell Palmer & & Dodge LLP
Euroscreen s.a.
Li Ruixiang
Williams Kathleen
LandOfFree
Isolated ligand of ChemerinR does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated ligand of ChemerinR, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated ligand of ChemerinR will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3980076